Global Veterinary Oncology Market Growth (Status and Outlook) 2025-2031

September 2025 | 112 pages | ID: G993E72D7C70EN
LP Information

Abstracts

According to this study, the global Veterinary Oncology market size will reach US$ million by 2031.

Veterinary oncology is a subspecialty of veterinary medicine that deals with cancer diagnosis and treatment in animals.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 115%.

LPI (LP Information)' newest research report, the “Veterinary Oncology Industry Forecast” looks at past sales and reviews total world Veterinary Oncology sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Oncology sales for 2025 through 2031. With Veterinary Oncology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Oncology industry.

This Insight Report provides a comprehensive analysis of the global Veterinary Oncology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Veterinary Oncology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Oncology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Oncology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Oncology.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Oncology market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Surgery
• Radiology
• Chemotherapy
• Immunotherapy
• Others (Combination Therapy, Targeted Therapy)

Segmentation by Application:

• Canine
• Feline

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• PetCure Oncology
• Accuray Incorporated
• Varian Medical Systems
• Boehringer Ingelheim
• Elanco
• Zoetis Karyopharm Therapeutics, Inc.
• One Health
• Regeneus Ltd.
• Nippon Zenyaku Kogyo Co., Ltd.
• Morphogenesis, Inc.
• Karyopharm Therapeutics, Inc.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Veterinary Oncology Market Size (2020-2031)
  2.1.2 Veterinary Oncology Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Veterinary Oncology by Country/Region (2020, 2024 & 2031)
2.2 Veterinary Oncology Segment by Type
  2.2.1 Surgery
  2.2.2 Radiology
  2.2.3 Chemotherapy
  2.2.4 Immunotherapy
  2.2.5 Others (Combination Therapy, Targeted Therapy)
2.3 Veterinary Oncology Market Size by Type
  2.3.1 Veterinary Oncology Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Veterinary Oncology Market Size Market Share by Type (2020-2025)
2.4 Veterinary Oncology Segment by Application
  2.4.1 Canine
  2.4.2 Feline
2.5 Veterinary Oncology Market Size by Application
  2.5.1 Veterinary Oncology Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Veterinary Oncology Market Size Market Share by Application (2020-2025)

3 VETERINARY ONCOLOGY MARKET SIZE BY PLAYER

3.1 Veterinary Oncology Market Size Market Share by Player
  3.1.1 Global Veterinary Oncology Revenue by Player (2020-2025)
  3.1.2 Global Veterinary Oncology Revenue Market Share by Player (2020-2025)
3.2 Global Veterinary Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 VETERINARY ONCOLOGY BY REGION

4.1 Veterinary Oncology Market Size by Region (2020-2025)
4.2 Global Veterinary Oncology Annual Revenue by Country/Region (2020-2025)
4.3 Americas Veterinary Oncology Market Size Growth (2020-2025)
4.4 APAC Veterinary Oncology Market Size Growth (2020-2025)
4.5 Europe Veterinary Oncology Market Size Growth (2020-2025)
4.6 Middle East & Africa Veterinary Oncology Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Veterinary Oncology Market Size by Country (2020-2025)
5.2 Americas Veterinary Oncology Market Size by Type (2020-2025)
5.3 Americas Veterinary Oncology Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Veterinary Oncology Market Size by Region (2020-2025)
6.2 APAC Veterinary Oncology Market Size by Type (2020-2025)
6.3 APAC Veterinary Oncology Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Veterinary Oncology Market Size by Country (2020-2025)
7.2 Europe Veterinary Oncology Market Size by Type (2020-2025)
7.3 Europe Veterinary Oncology Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Veterinary Oncology by Region (2020-2025)
8.2 Middle East & Africa Veterinary Oncology Market Size by Type (2020-2025)
8.3 Middle East & Africa Veterinary Oncology Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL VETERINARY ONCOLOGY MARKET FORECAST

10.1 Global Veterinary Oncology Forecast by Region (2026-2031)
  10.1.1 Global Veterinary Oncology Forecast by Region (2026-2031)
  10.1.2 Americas Veterinary Oncology Forecast
  10.1.3 APAC Veterinary Oncology Forecast
  10.1.4 Europe Veterinary Oncology Forecast
  10.1.5 Middle East & Africa Veterinary Oncology Forecast
10.2 Americas Veterinary Oncology Forecast by Country (2026-2031)
  10.2.1 United States Market Veterinary Oncology Forecast
  10.2.2 Canada Market Veterinary Oncology Forecast
  10.2.3 Mexico Market Veterinary Oncology Forecast
  10.2.4 Brazil Market Veterinary Oncology Forecast
10.3 APAC Veterinary Oncology Forecast by Region (2026-2031)
  10.3.1 China Veterinary Oncology Market Forecast
  10.3.2 Japan Market Veterinary Oncology Forecast
  10.3.3 Korea Market Veterinary Oncology Forecast
  10.3.4 Southeast Asia Market Veterinary Oncology Forecast
  10.3.5 India Market Veterinary Oncology Forecast
  10.3.6 Australia Market Veterinary Oncology Forecast
10.4 Europe Veterinary Oncology Forecast by Country (2026-2031)
  10.4.1 Germany Market Veterinary Oncology Forecast
  10.4.2 France Market Veterinary Oncology Forecast
  10.4.3 UK Market Veterinary Oncology Forecast
  10.4.4 Italy Market Veterinary Oncology Forecast
  10.4.5 Russia Market Veterinary Oncology Forecast
10.5 Middle East & Africa Veterinary Oncology Forecast by Region (2026-2031)
  10.5.1 Egypt Market Veterinary Oncology Forecast
  10.5.2 South Africa Market Veterinary Oncology Forecast
  10.5.3 Israel Market Veterinary Oncology Forecast
  10.5.4 Turkey Market Veterinary Oncology Forecast
10.6 Global Veterinary Oncology Forecast by Type (2026-2031)
10.7 Global Veterinary Oncology Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Veterinary Oncology Forecast

11 KEY PLAYERS ANALYSIS

11.1 PetCure Oncology
  11.1.1 PetCure Oncology Company Information
  11.1.2 PetCure Oncology Veterinary Oncology Product Offered
  11.1.3 PetCure Oncology Veterinary Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 PetCure Oncology Main Business Overview
  11.1.5 PetCure Oncology Latest Developments
11.2 Accuray Incorporated
  11.2.1 Accuray Incorporated Company Information
  11.2.2 Accuray Incorporated Veterinary Oncology Product Offered
  11.2.3 Accuray Incorporated Veterinary Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Accuray Incorporated Main Business Overview
  11.2.5 Accuray Incorporated Latest Developments
11.3 Varian Medical Systems
  11.3.1 Varian Medical Systems Company Information
  11.3.2 Varian Medical Systems Veterinary Oncology Product Offered
  11.3.3 Varian Medical Systems Veterinary Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Varian Medical Systems Main Business Overview
  11.3.5 Varian Medical Systems Latest Developments
11.4 Boehringer Ingelheim
  11.4.1 Boehringer Ingelheim Company Information
  11.4.2 Boehringer Ingelheim Veterinary Oncology Product Offered
  11.4.3 Boehringer Ingelheim Veterinary Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Boehringer Ingelheim Main Business Overview
  11.4.5 Boehringer Ingelheim Latest Developments
11.5 Elanco
  11.5.1 Elanco Company Information
  11.5.2 Elanco Veterinary Oncology Product Offered
  11.5.3 Elanco Veterinary Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Elanco Main Business Overview
  11.5.5 Elanco Latest Developments
11.6 Zoetis Karyopharm Therapeutics, Inc.
  11.6.1 Zoetis Karyopharm Therapeutics, Inc. Company Information
  11.6.2 Zoetis Karyopharm Therapeutics, Inc. Veterinary Oncology Product Offered
  11.6.3 Zoetis Karyopharm Therapeutics, Inc. Veterinary Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Zoetis Karyopharm Therapeutics, Inc. Main Business Overview
  11.6.5 Zoetis Karyopharm Therapeutics, Inc. Latest Developments
11.7 One Health
  11.7.1 One Health Company Information
  11.7.2 One Health Veterinary Oncology Product Offered
  11.7.3 One Health Veterinary Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 One Health Main Business Overview
  11.7.5 One Health Latest Developments
11.8 Regeneus Ltd.
  11.8.1 Regeneus Ltd. Company Information
  11.8.2 Regeneus Ltd. Veterinary Oncology Product Offered
  11.8.3 Regeneus Ltd. Veterinary Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Regeneus Ltd. Main Business Overview
  11.8.5 Regeneus Ltd. Latest Developments
11.9 Nippon Zenyaku Kogyo Co., Ltd.
  11.9.1 Nippon Zenyaku Kogyo Co., Ltd. Company Information
  11.9.2 Nippon Zenyaku Kogyo Co., Ltd. Veterinary Oncology Product Offered
  11.9.3 Nippon Zenyaku Kogyo Co., Ltd. Veterinary Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Nippon Zenyaku Kogyo Co., Ltd. Main Business Overview
  11.9.5 Nippon Zenyaku Kogyo Co., Ltd. Latest Developments
11.10 Morphogenesis, Inc.
  11.10.1 Morphogenesis, Inc. Company Information
  11.10.2 Morphogenesis, Inc. Veterinary Oncology Product Offered
  11.10.3 Morphogenesis, Inc. Veterinary Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Morphogenesis, Inc. Main Business Overview
  11.10.5 Morphogenesis, Inc. Latest Developments
11.11 Karyopharm Therapeutics, Inc.
  11.11.1 Karyopharm Therapeutics, Inc. Company Information
  11.11.2 Karyopharm Therapeutics, Inc. Veterinary Oncology Product Offered
  11.11.3 Karyopharm Therapeutics, Inc. Veterinary Oncology Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Karyopharm Therapeutics, Inc. Main Business Overview
  11.11.5 Karyopharm Therapeutics, Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Veterinary Oncology Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Veterinary Oncology Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Surgery
Table 4. Major Players of Radiology
Table 5. Major Players of Chemotherapy
Table 6. Major Players of Immunotherapy
Table 7. Major Players of Others (Combination Therapy, Targeted Therapy)
Table 8. Veterinary Oncology Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Veterinary Oncology Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Veterinary Oncology Market Size Market Share by Type (2020-2025)
Table 11. Veterinary Oncology Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Veterinary Oncology Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Veterinary Oncology Market Size Market Share by Application (2020-2025)
Table 14. Global Veterinary Oncology Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Veterinary Oncology Revenue Market Share by Player (2020-2025)
Table 16. Veterinary Oncology Key Players Head office and Products Offered
Table 17. Veterinary Oncology Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Veterinary Oncology Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Veterinary Oncology Market Size Market Share by Region (2020-2025)
Table 22. Global Veterinary Oncology Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Veterinary Oncology Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Veterinary Oncology Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Veterinary Oncology Market Size Market Share by Country (2020-2025)
Table 26. Americas Veterinary Oncology Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Veterinary Oncology Market Size Market Share by Type (2020-2025)
Table 28. Americas Veterinary Oncology Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Veterinary Oncology Market Size Market Share by Application (2020-2025)
Table 30. APAC Veterinary Oncology Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Veterinary Oncology Market Size Market Share by Region (2020-2025)
Table 32. APAC Veterinary Oncology Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Veterinary Oncology Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Veterinary Oncology Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Veterinary Oncology Market Size Market Share by Country (2020-2025)
Table 36. Europe Veterinary Oncology Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Veterinary Oncology Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Veterinary Oncology Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Veterinary Oncology Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Veterinary Oncology Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Veterinary Oncology
Table 42. Key Market Challenges & Risks of Veterinary Oncology
Table 43. Key Industry Trends of Veterinary Oncology
Table 44. Global Veterinary Oncology Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Veterinary Oncology Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Veterinary Oncology Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Veterinary Oncology Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. PetCure Oncology Details, Company Type, Veterinary Oncology Area Served and Its Competitors
Table 49. PetCure Oncology Veterinary Oncology Product Offered
Table 50. PetCure Oncology Veterinary Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. PetCure Oncology Main Business
Table 52. PetCure Oncology Latest Developments
Table 53. Accuray Incorporated Details, Company Type, Veterinary Oncology Area Served and Its Competitors
Table 54. Accuray Incorporated Veterinary Oncology Product Offered
Table 55. Accuray Incorporated Veterinary Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Accuray Incorporated Main Business
Table 57. Accuray Incorporated Latest Developments
Table 58. Varian Medical Systems Details, Company Type, Veterinary Oncology Area Served and Its Competitors
Table 59. Varian Medical Systems Veterinary Oncology Product Offered
Table 60. Varian Medical Systems Veterinary Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Varian Medical Systems Main Business
Table 62. Varian Medical Systems Latest Developments
Table 63. Boehringer Ingelheim Details, Company Type, Veterinary Oncology Area Served and Its Competitors
Table 64. Boehringer Ingelheim Veterinary Oncology Product Offered
Table 65. Boehringer Ingelheim Veterinary Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Boehringer Ingelheim Main Business
Table 67. Boehringer Ingelheim Latest Developments
Table 68. Elanco Details, Company Type, Veterinary Oncology Area Served and Its Competitors
Table 69. Elanco Veterinary Oncology Product Offered
Table 70. Elanco Veterinary Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Elanco Main Business
Table 72. Elanco Latest Developments
Table 73. Zoetis Karyopharm Therapeutics, Inc. Details, Company Type, Veterinary Oncology Area Served and Its Competitors
Table 74. Zoetis Karyopharm Therapeutics, Inc. Veterinary Oncology Product Offered
Table 75. Zoetis Karyopharm Therapeutics, Inc. Veterinary Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Zoetis Karyopharm Therapeutics, Inc. Main Business
Table 77. Zoetis Karyopharm Therapeutics, Inc. Latest Developments
Table 78. One Health Details, Company Type, Veterinary Oncology Area Served and Its Competitors
Table 79. One Health Veterinary Oncology Product Offered
Table 80. One Health Veterinary Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. One Health Main Business
Table 82. One Health Latest Developments
Table 83. Regeneus Ltd. Details, Company Type, Veterinary Oncology Area Served and Its Competitors
Table 84. Regeneus Ltd. Veterinary Oncology Product Offered
Table 85. Regeneus Ltd. Veterinary Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Regeneus Ltd. Main Business
Table 87. Regeneus Ltd. Latest Developments
Table 88. Nippon Zenyaku Kogyo Co., Ltd. Details, Company Type, Veterinary Oncology Area Served and Its Competitors
Table 89. Nippon Zenyaku Kogyo Co., Ltd. Veterinary Oncology Product Offered
Table 90. Nippon Zenyaku Kogyo Co., Ltd. Veterinary Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Nippon Zenyaku Kogyo Co., Ltd. Main Business
Table 92. Nippon Zenyaku Kogyo Co., Ltd. Latest Developments
Table 93. Morphogenesis, Inc. Details, Company Type, Veterinary Oncology Area Served and Its Competitors
Table 94. Morphogenesis, Inc. Veterinary Oncology Product Offered
Table 95. Morphogenesis, Inc. Veterinary Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Morphogenesis, Inc. Main Business
Table 97. Morphogenesis, Inc. Latest Developments
Table 98. Karyopharm Therapeutics, Inc. Details, Company Type, Veterinary Oncology Area Served and Its Competitors
Table 99. Karyopharm Therapeutics, Inc. Veterinary Oncology Product Offered
Table 100. Karyopharm Therapeutics, Inc. Veterinary Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. Karyopharm Therapeutics, Inc. Main Business
Table 102. Karyopharm Therapeutics, Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Veterinary Oncology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Veterinary Oncology Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Veterinary Oncology Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Veterinary Oncology Sales Market Share by Country/Region (2024)
Figure 8. Veterinary Oncology Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Veterinary Oncology Market Size Market Share by Type in 2024
Figure 10. Veterinary Oncology in Canine
Figure 11. Global Veterinary Oncology Market: Canine (2020-2025) & ($ millions)
Figure 12. Veterinary Oncology in Feline
Figure 13. Global Veterinary Oncology Market: Feline (2020-2025) & ($ millions)
Figure 14. Global Veterinary Oncology Market Size Market Share by Application in 2024
Figure 15. Global Veterinary Oncology Revenue Market Share by Player in 2024
Figure 16. Global Veterinary Oncology Market Size Market Share by Region (2020-2025)
Figure 17. Americas Veterinary Oncology Market Size 2020-2025 ($ millions)
Figure 18. APAC Veterinary Oncology Market Size 2020-2025 ($ millions)
Figure 19. Europe Veterinary Oncology Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Veterinary Oncology Market Size 2020-2025 ($ millions)
Figure 21. Americas Veterinary Oncology Value Market Share by Country in 2024
Figure 22. United States Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Veterinary Oncology Market Size Market Share by Region in 2024
Figure 27. APAC Veterinary Oncology Market Size Market Share by Type (2020-2025)
Figure 28. APAC Veterinary Oncology Market Size Market Share by Application (2020-2025)
Figure 29. China Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 33. India Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Veterinary Oncology Market Size Market Share by Country in 2024
Figure 36. Europe Veterinary Oncology Market Size Market Share by Type (2020-2025)
Figure 37. Europe Veterinary Oncology Market Size Market Share by Application (2020-2025)
Figure 38. Germany Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 39. France Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Veterinary Oncology Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Veterinary Oncology Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Veterinary Oncology Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Veterinary Oncology Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 52. APAC Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 53. Europe Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 55. United States Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 56. Canada Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 57. Mexico Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 58. Brazil Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 59. China Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 60. Japan Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 61. Korea Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 63. India Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 64. Australia Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 65. Germany Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 66. France Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 67. UK Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 68. Italy Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 69. Russia Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 70. Egypt Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 71. South Africa Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 72. Israel Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 73. Turkey Veterinary Oncology Market Size 2026-2031 ($ millions)
Figure 74. Global Veterinary Oncology Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Veterinary Oncology Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Veterinary Oncology Market Size 2026-2031 ($ millions)